Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

PRP is a safe and effective treatment for limited alopecia areata.

PAON shows skin patterns due to genetic mosaicism.

Arg1+ macrophages may play a role in causing alopecia areata.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Alopecia areata may be caused by the immune system attacking hair follicles.

Targeting specific T cells may help treat alopecia areata.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Blood count parameters are not reliable for predicting recurrent implantation failure.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Belatacept may be a promising treatment for alopecia areata.

A PKP1 gene mutation causes skin fragility and hair loss in Chesapeake Bay retriever puppies.

Pili annulati is caused by a protein metabolism disorder affecting hair structure.

Different skin diseases show unique patterns of skin cell separation, cell death, and granular layer changes.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Removing alkaline phosphatase from human skin cells hinders the creation of new hair follicles.

Alopecia neoplastica is hair loss from breast cancer spreading to the scalp.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.